drug
as of 2026-07-01Extract of Ginkgo Biloba (EGb-761 capsules)
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Beijing HuiLongGuan Hospital
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Extract of Ginkgo Biloba and Tardive Dyskinesia
NCT00672373Phase 3Completed
KOLs & investigators
2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
indication
KOL
Yunlong Tan, Phd
personKOL score —
Dongfeng Zhou, Professor
personKOL score —